News

Number of news items returned: 141 to 160 records of 411

Opmantek's Strong International Growth Continues

05 September 2016

(12796 views)

"Opmantek’s period of strong growth has continued with previous quarter results seeing Europe emerging as the top performing region for the ...

Benojo - Latest News - September 2016

02 September 2016

(11989 views)

"Benojo reached a milestone of 7,000 users...growing its team and business development capacity..will launch its bespoke products in October..." Martyn Ryan, ...

Ocular Robotics invited to demonstrate at Army Innovation Day 2016

24 August 2016

(11725 views)

"In a highly competitive process Ocular Robotics has been invited to demonstrate an Immersive Telepresence System based on its RobotEye ...

ATIC Update: Round 2 Fully Subscribed & Latest Progress Report

24 August 2016

(12183 views)

ATIC Update: Round 2 Fully Subscribed & Latest Progress Report Round 2 fully subscribed. Progressing in offering execution & funds management services Property ...

Benojo - Latest News - August 2016

04 August 2016

(11978 views)

"Benojo secure $200,000 in R&D grants from federal Government... extends its tech capability to now include the general public..." Martyn Ryan, CEO, ...

Chat2, Cricket and much more - Funding Strategies Connect July August 2016

02 August 2016

(11665 views)

Dear Reader, Thank you for your interest in our company and services. We strive to provide successful introductions between profitable, expanding ...

ATIC announces Change of Director

19 July 2016

(12099 views)

"...it’s with pleasure that I can announce that Mr. Paul De Groot has joined the board of ATIC." Daniel Hendry, Managing ...

Completion of Squirel Limited Due Diligence

19 July 2016

(12181 views)

"Further to the announcement on 8 July 2016,  Metallum Limited is pleased to provide an update on its  proposed acquisition ...

Freedom Suites Launch at Brisbane Hair and Beauty Expo

19 July 2016

(12273 views)

"Freedom Suites has officially launched the salon suite concept at Brisbane Hair and Beauty Expo, 17th and 18th July, with ...

Benojo - Latest News - July 2016

19 July 2016

(12003 views)

"Benojo celebrate almost $3m of donations on its platform in 2016...reach a milestone of 6000 users and 50 corporate clients" Martyn ...

Capital Raising progressing with Round 1 fully subscribed

15 July 2016

(11850 views)

"Freedom Suites Ltd has recently closed Round 1 of its capital raising fully subscribed and has extended the offer for ...

Ocular Robotics ASSOB offer closing 17 July 2016

12 July 2016

(12646 views)

"Ocular Robotics’ current share offer on the ASSOB board closes on the 17th July 2016 and I would like to ...

DSTG Therman Stress Analysis Collaboration Featured at Partnerships Week

12 July 2016

(11846 views)

"As reported earlier the Defence Science Technology Group (DSTG) have through an R&D collaboration been pursuing a development with Ocular ...

Incentives, Introductions and News - Funding Strategies Connect June July 2016

01 July 2016

(10452 views)

Dear Readers, From 1st July 2016, the Australian Government is introducing tax incentives for early stage investors. "If you invest in ...

Nifty R&D Special Offer

30 June 2016

(12256 views)

"Submit with Nifty R&D on or before 31st Aug to receive 25% off the cost of your R&D claim" Brendan White, ...

Qponics awarded $1m CRC-P Grant

30 June 2016

(11864 views)

"Queensland-based omega-3 algae farming company, Qponics, has been awarded a $1 million grant to construct a commercial-sized algae farm in ...

Freedom Suites to exhibit at Brisbane Hair and Beauty Expo

29 June 2016

(11790 views)

"Freedom Suites are pleased to announce that they will be exhibiting at the upcoming Brisbane Hair and Beauty Expo on ...

Opmantek continues strong growth and increases presence with new configuration technology

27 June 2016

(12648 views)

"Opmantek continues strong growth and increases presence in the Network Automation Market with new configuration technology" Danny Maher, Managing Director, Opmantek ...

ICS June news

24 June 2016

(11562 views)

"Certification Bodies Seek to Bridge their Skills Shortage", "Cutting Edge and Exclusive Food Security Training", "Asian Footprint in Training and ...

Squirrel & Metallum Sign Binding Heads of Agreement

17 June 2016

(12824 views)

"The Board of Metallum Limited (ASX:MNE) is pleased to announce that it has executed share sale agreements with the shareholders ...

JNCI publication involving CytImmune's CYT-21625

10 March 18

 

"JNCI publication involving CytImmune's CYT-21625"

 

"Please find attached [via the link below] an article published in the most recent version of the Journal of the National Cancer Institute (JNCI). This publication reports on a series of animal experiments comparing CytImmune's second generation nanomedicine, CYT-21625, against the commonly used chemotherapy, paclitaxel.


Key points:

1) CYT-21625 was safe with no toxicities observed.
2) The study involved three cancer models:
• Two thyroid cancers, traditional mouse xenograft models
• One Pancreatic neuroendocrine cancer, a genetically engineered mouse model.
3) Both anaplastic thyroid cancer (ATC) and pancreatic neuroendorine cancer (PNETs) are rare/orphan diseases, and have abysmal 5 year survival rates -- less than 5% for ATC and 16% for PNET patients with advanced disease.
4) CYT-21625 out-performed paclitaxel as measured by overall survival and using biological indicators that were specific to each cancer and model used.
We believe this study confirms the potential of the the Aurimune platform to deliver existing cancer drugs more effectively and with fewer toxic side effects. The paper concludes:

"CYT-21625 is effective in mice with PNETs [Pancreatic NeuroEndocrine Tumors] and metastatic human thyroid cancer with no toxicities. Thus, CYT-21625 should be studied in patients with advanced PNETs and thyroid cancer."

*Note that this study also used a CYT-6091 monotherapy as a control. As expected in this setting, while CYT-6091 showed some limited efficacy, it was inferior to therapies in which TNF is delivered in combination with chemotherapy. "

 

David Oarr, Chief Communications Officer, Project Karkinos, 10 March 2018.

Additional Documents

JNCI_CYT21625